🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans

Yatin Suneja

Stock Analyst at Guggenheim

(4.87)
# 301
Out of 5,144 analysts
463
Total ratings
48.3%
Success rate
21.2%
Average return

Stocks Rated by Yatin Suneja

Neumora Therapeutics
Nov 18, 2026
Reiterated: Buy
Price Target: $14 → $8
Current: $0.3345
Upside: +2,291.63%
Lycia Therapeutics
Nov 17, 2026
Initiated Coverage: Buy
Price Target: $75
Current: $30.92
Upside: +142.56%
Yarrow Bioscience
Nov 15, 2026
Reiterated: Buy
Price Target: $60
Current: $14.21
Upside: +322.24%
Alumis
Nov 13, 2026
Reiterated: Hold
Price Target: n/a
Current: $4.84
Upside: -
EyePoint
Nov 13, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.2959
Upside: -
Praxis Precision Medicines
Nov 13, 2026
Reiterated: Buy
Price Target: $800 → $1,050
Current: $305.06
Upside: +244.19%
Roivant Sciences
Nov 13, 2026
Reiterated: Buy
Price Target: $46 → $48
Current: $38.71
Upside: +24.00%
Surrozen
Nov 11, 2026
Reiterated: Buy
Price Target: $45 → $80
Current: $29.98
Upside: +166.84%
Zura Bio
Nov 10, 2026
Reiterated: Buy
Price Target: $20 → $8
Current: $1.04
Upside: +672.95%
Immunic
Nov 9, 2026
Reiterated: Buy
Price Target: $70
Current: $7.33
Upside: +854.98%
Reiterated: Buy
Price Target: $100
Current: $28.04
Upside: +256.63%
Reiterated: Buy
Price Target: $100 → $55
Current: $2.78
Upside: +1,878.42%
Reiterated: Buy
Price Target: $35
Current: $9.78
Upside: +257.87%
Reiterated: Buy
Price Target: $70
Current: $32.50
Upside: +115.38%
Reiterated: Buy
Price Target: $50
Current: $13.76
Upside: +263.37%
Reiterated: Buy
Price Target: $275 → $250
Current: $135.95
Upside: +83.89%
Reiterated: Buy
Price Target: $45 → $40
Current: $7.51
Upside: +432.62%
Reiterated: Buy
Price Target: $130 → $135
Current: $93.81
Upside: +43.91%
Reiterated: Buy
Price Target: $100 → $110
Current: $43.57
Upside: +152.47%
Reiterated: Buy
Price Target: $280 → $300
Current: $250.79
Upside: +19.62%
Reiterated: Buy
Price Target: $1,030 → $1,100
Current: $957.76
Upside: +14.85%
Reiterated: Buy
Price Target: $51 → $46
Current: $9.99
Upside: +360.46%
Reiterated: Buy
Price Target: $22
Current: $5.50
Upside: +300.00%
Reiterated: Buy
Price Target: $55
Current: $27.75
Upside: +98.20%
Downgraded: Hold
Price Target: n/a
Current: $7.13
Upside: -
Reiterated: Buy
Price Target: $1,185 → $1,120
Current: $947.52
Upside: +18.20%
Reiterated: Buy
Price Target: $175
Current: $82.10
Upside: +113.15%
Reiterated: Hold
Price Target: n/a
Current: $3.07
Upside: -
Reiterated: Buy
Price Target: $16
Current: $1.02
Upside: +1,468.63%
Reiterated: Buy
Price Target: $200
Current: $96.32
Upside: +107.64%
Reiterated: Buy
Price Target: $90
Current: $38.78
Upside: +132.08%
Reiterated: Buy
Price Target: $200
Current: $86.98
Upside: +129.94%
Reiterated: Buy
Price Target: $200 → $222
Current: $165.92
Upside: +33.80%
Reiterated: Buy
Price Target: $44 → $62
Current: $33.21
Upside: +86.69%
Reiterated: Buy
Price Target: $15
Current: $2.95
Upside: +408.47%
Reiterated: Buy
Price Target: $14
Current: $1.15
Upside: +1,117.39%
Reiterated: Buy
Price Target: $60
Current: $26.41
Upside: +127.19%
Reiterated: Buy
Price Target: $140
Current: $45.61
Upside: +206.95%
Reiterated: Buy
Price Target: $20
Current: $11.25
Upside: +77.78%
Reiterated: Buy
Price Target: $26
Current: $2.99
Upside: n/a
Reiterated: Hold
Price Target: $20
Current: $18.32
Upside: n/a
Downgraded: Hold
Price Target: n/a
Current: $8.63
Upside: n/a
Downgraded: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Reiterated: Hold
Price Target: n/a
Current: $3.01
Upside: n/a
Initiated Coverage: Buy
Price Target: $24
Current: $20.83
Upside: n/a
Reiterated: Buy
Price Target: $9
Current: $1.08
Upside: n/a
Reiterated: Buy
Price Target: $115 → $123
Current: $29.89
Upside: n/a
Initiated Coverage: Buy
Price Target: $12
Current: $0.7948
Upside: n/a
Reiterated: Buy
Price Target: $21 → $32
Current: $13.04
Upside: n/a
Rated: Buy
Price Target: n/a
Current: $62.71
Upside: n/a
Reiterated: Buy
Price Target: n/a
Current: $13.92
Upside: n/a